Abstract

MO2-2 Post-marketing observational safety study of durvalumab in Japanese patients with unresectable stage III NSCLC (PACIFIC regimen)

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Long-term safety and effectiveness of biosimilar insulin glargine in Japanese patients with diabetes mellitus in routine clinical practice: results of a post-marketing safety study
Tomotaka Shingaki ... Takeshi Imaoka
Current Medical Research and Opinion | VOL. 36
Tomotaka Shingaki, et. al.Tomotaka Shingaki ... Takeshi Imaoka
23 Apr 2020
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study
Teresa A Simon ... Andres Gomez
Seminars in Arthritis and Rheumatism | VOL. 64
Teresa A Simon, et. al.Teresa A Simon ... Andres Gomez
30 Jun 2023
Safety and effectiveness of tofogliflozin in Japanese patients with type2 diabetes mellitus treated in real-world clinical practice: Results of a 36-month post-marketing surveillance study (J-STEP/LT).
Kazunori Utsunomiya ... Masayuki Senda
Journal of diabetes investigation | VOL. 12
Kazunori Utsunomiya, et. al.Kazunori Utsunomiya ... Masayuki Senda
25 Aug 2020
Abstract 5052: Mechanistic pharmacodynamic analysis on safety profiles of eribulin in patients with breast cancer using data obtained by post-marketing observational study
Takahisa Kawamura ... Yusuke Tanigawara
Cancer Research | VOL. 77
Takahisa Kawamura, et. al.Takahisa Kawamura ... Yusuke Tanigawara
01 Jul 2017
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial
N.M Tannir ... R.J Motzer
Annals of Oncology | VOL. -
N.M Tannir, et. al.N.M Tannir ... R.J Motzer
01 Aug 2024
A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance two years later
A Di Meglio ... I Vaz-Luis
Annals of Oncology | VOL. -
A Di Meglio, et. al.A Di Meglio ... I Vaz-Luis
01 Aug 2024
Tumour Heterogeneity in Molecular Imaging for Breast Cancer
Soraia Lobo-Martins ... Géraldine Gebhart
Annals of Oncology | VOL. -
Soraia Lobo-Martins, et. al.Soraia Lobo-Martins ... Géraldine Gebhart
01 Aug 2024
Exploiting the tumor microenvironment and tumor mechanobiology for the treatment of cancer cachexia
Kostas A Papavassiliou ... Athanasios G Papavassiliou
Annals of Oncology | VOL. -
Kostas A Papavassiliou, et. al.Kostas A Papavassiliou ... Athanasios G Papavassiliou
23 Jul 2024
View more papers